Biomarker signatures of mitochondrial NDUFS3 in invasive breast carcinoma

Biochemical and Biophysical Research Communications

Volumn 412, Issue 4, 2011, Pages 590-595

  Suhane, Sonal ^a   Berel, Dror ^a   Ramanujan, V Krishnan ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Biomarkers; Breast carcinoma; Hypoxia; Mitochondrial Complex I; NDUFS3

Indexed keywords

NADH DEHYDROGENASE (UBIQUINONE) IRON SULPHUR PROTEIN 3; OXIDOREDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER GROWTH; CANCER SURVIVAL; CANCER TISSUE; CELL TRANSFORMATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BREAST NEOPLASMS; CARCINOMA; FEMALE; HUMANS; MITOCHONDRIA; NADH DEHYDROGENASE; NEOPLASM INVASIVENESS; RNA, SMALL INTERFERING; TUMOR MARKERS, BIOLOGICAL;

EID: 80052622984     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.08.003     Document Type: Article

References (29)

1. Patani N., Cutuli B., Mokbel K. Current management of DCIS: a review. Breast Cancer Res. Treat. 2008, 111:1-10.
2. B.A. Virnig, T. Shamliyan, T.M. Tuttle, R.L. Kane, T.J. Wilt, Diagnosis and management of ductal carcinoma in situ (DCIS). Evid. Rep. Technol. Assess (Full Rep) (2009) 1-549.
3. O'Driscoll L., Clynes M. Biomarkers and multiple drug resistance in breast cancer. Curr. Cancer Drug Targets 2006, 6:365-384.
4. McArthur H.L., Dickler M.N. Biomarkers in breast cancer. Cancer Biol. Ther. 2008, 7:21-22.
5. Ross J.S., Linette G.P., Stec J., Clark E., Ayers M., Leschly N., Symmans W.F., Hortobagyi G.N., Pusztai L. Breast cancer biomarkers and molecular medicine. Expert Rev. Mol. Diagn. 2003, 3:573-585.
6. Ross J.S. Breast cancer biomarkers and HER2 testing after 10 years of anti-HER2 therapy. Drug News Perspect. 2009, 22:93-106.
7. Santisteban M., Reynolds C., Barr Fritcher E.G., Frost M.H., Vierkant R.A., Anderson S.S., Degnim A.C., Visscher D.W., Pankratz V.S., Hartmann L.C. Ki67: a time-varying biomarker of risk of breast cancer in atypical hyperplasia. Breast Cancer Res. Treat. 2010, 121:431-437.
8. Thompson C.B. Metabolic enzymes as oncogenes or tumor suppressors. New Engl. J. Med. 2009, 360:813-815.
9. Tennant D.A., Duran R.V., Boulahbel H., Gottlieb E. Metabolic transformation in cancer. Carcinogenesis 2009, 30:1269-1280.
10. Bellance N., Lestienne P., Rossignol R. Mitochondria: from bioenergetics to the metabolic regulation of carcinogenesis. Front. Biosci. 2009, 14:4015-4034.
11. Perou C.M., Sorlie T., Eisen M.B., van de Rijn M., Jeffrey S.S., Rees C.A., Pollack J.R., Ross D.T., Johnsen H., Akslen L.A., Fluge O., Pergamenschikov A., Williams C., Zhu S.X., Lonning P.E., Borresen-Dale A.L., Brown P.O., Botstein D. Molecular portraits of human breast tumours. Nature 2000, 406:747-752.
12. Petit P.X., Zamzami N., Vayssiere J.L., Mignotte B., Kroemer G., Castedo M. Implication of mitochondria in apoptosis. Mol. Cell. Biochem. 1997, 174:185-188.
13. Zamzami N., Larochette N., Kroemer G. Mitochondrial permeability transition in apoptosis and necrosis. Cell Death Differ. 2005, 12(Suppl 2):1478-1480.
14. Benit P., Slama A., Cartault F., Giurgea I., Chretien D., Lebon S., Marsac C., Munnich A., Rotig A., Rustin P. Mutant NDUFS3 subunit of mitochondrial complex I causes Leigh syndrome. J. Med. Genet. 2004, 41:14-17.
15. Dieteren C.E., Willems P.H., Vogel R.O., Swarts H.G., Fransen J., Roepman R., Crienen G., Smeitink J.A., Nijtmans L.G., Koopman W.J. Subunits of mitochondrial complex I exist as part of matrix- and membrane-associated subcomplexes in living cells. J. Biol. Chem. 2008, 283:34753-34761.
16. Efremov R.G., Baradaran R., Sazanov L.A. The architecture of respiratory complex I. Nature 2010, 465:441-445.
17. Procaccio V., Lescuyer P., Bourges I., Beugnot R., Duborjal H., Depetris D., Mousson B., Montfort M.F., Smeets H., De Coo R., Issartel J.P. Human NDUFS3 gene coding for the 30-kDa subunit of mitochondrial complex I: genomic organization and expression. Mamm. Genome. 2000, 11:808-810.
18. Klimova T., Chandel N.S. Mitochondrial complex III regulates hypoxic activation of HIF. Cell. Death Differ. 2008, 15:660-666.
19. Saada A., Vogel R.O., Hoefs S.J., van den Brand M.A., Wessels H.J., Willems P.H., Venselaar H., Shaag A., Barghuti F., Reish O., Shohat M., Huynen M.A., Smeitink J.A., van den Heuvel L.P., Nijtmans L.G. Mutations in NDUFAF3 (C3ORF60), encoding an NDUFAF4 (C6ORF66)-interacting complex I assembly protein, cause fatal neonatal mitochondrial disease. Am. J. Hum. Genet. 2009, 84:718-727.
20. Warburg O. On respiratory impairment in cancer cells. Science 1956, 124:269-270.
21. Nyirenda N., Farkas D.L., Ramanujan V.K. Preclinical evaluation of nuclear morphometry and tissue topology for breast carcinoma detection and margin assessment. Breast Cancer Res. Treat. 2011, 126:345-354.
22. Huang G., Chen Y., Lu H., Cao X. Coupling mitochondrial respiratory chain to cell death: an essential role of mitochondrial complex I in the interferon-beta and retinoic acid-induced cancer cell death. Cell Death Differ. 2007, 14:327-337.
23. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
24. Mathupala S.P., Ko Y.H., Pedersen P.L. Hexokinase-2 bound to mitochondria: cancer's stygian link to the " Warburg Effect" and a pivotal target for effective therapy. Semin. Cancer Biol. 2009, 19:17-24.
25. Soderdahl T., Enoksson M., Lundberg M., Holmgren A., Ottersen O.P., Orrenius S., Bolcsfoldi G., Cotgreave I.A. Visualization of the compartmentalization of glutathione and protein-glutathione mixed disulfides in cultured cells. Faseb J. 2003, 17:124-126.
26. Ott M., Gogvadze V., Orrenius S., Zhivotovsky B. Mitochondria, oxidative stress and cell death. Apoptosis 2007, 12:913-922.
27. Vander Heiden M.G., Cantley L.C., Thompson C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324:1029-1033.
28. Trachootham D., Alexandre J., Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?. Nat. Rev. Drug Discov. 2009, 8:579-591.
29. Vogel R.O., Dieteren C.E., van den Heuvel L.P., Willems P.H., Smeitink J.A., Koopman W.J., Nijtmans L.G. Identification of mitochondrial complex I assembly intermediates by tracing tagged NDUFS3 demonstrates the entry point of mitochondrial subunits. J. Biol. Chem. 2007, 282:7582-7590.